vs
Ross Stores（ROST）与福泰制药（VRTX）财务数据对比。点击上方公司名可切换其他公司
Ross Stores的季度营收约是福泰制药的1.8倍（$5.6B vs $3.2B），福泰制药净利率更高（37.3% vs 9.1%，领先28.2%），Ross Stores同比增速更快（10.4% vs 9.5%），Ross Stores自由现金流更多（$617.8M vs $348.6M），过去两年福泰制药的营收复合增速更高（8.9% vs -3.6%）
Ross Stores, Inc.是美国知名折扣百货连锁集团，旗下核心品牌为Ross Dress for Less，总部位于加利福尼亚州都柏林，是美国规模最大的平价零售商。截至2024年7月，集团在全美43个州、华盛顿特区、波多黎各及关岛共运营1795家门店，暂未覆盖新英格兰地区及阿拉斯加，另拥有门店数超353家的折扣零售品牌DD's Discounts。
福泰制药是总部位于美国马萨诸塞州波士顿的生物制药企业，是全球首批明确采用理性药物设计策略、而非组合化学方法开发药物的生物技术公司之一。除波士顿总部外，公司还在加州圣迭戈、英国牛津郡米尔顿公园设有三处研发中心。
ROST vs VRTX — 直观对比
营收规模更大
ROST
是对方的1.8倍
$3.2B
营收增速更快
ROST
高出0.9%
9.5%
净利率更高
VRTX
高出28.2%
9.1%
自由现金流更多
ROST
多$269.2M
$348.6M
两年增速更快
VRTX
近两年复合增速
-3.6%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $5.6B | $3.2B |
| 净利润 | $511.9M | $1.2B |
| 毛利率 | 28.0% | 85.4% |
| 营业利润率 | 11.6% | 37.8% |
| 净利率 | 9.1% | 37.3% |
| 营收同比 | 10.4% | 9.5% |
| 净利润同比 | 4.7% | 30.5% |
| 每股收益（稀释后） | $1.58 | $4.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ROSTVRTX
| Q4 25 | $5.6B | $3.2B | ||
| Q3 25 | $5.5B | $3.1B | ||
| Q2 25 | $5.0B | $3.0B | ||
| Q1 25 | $5.9B | $2.8B | ||
| Q4 24 | $5.1B | $2.9B | ||
| Q3 24 | $5.3B | $2.8B | ||
| Q2 24 | $4.9B | $2.6B | ||
| Q1 24 | $6.0B | $2.7B |
净利润ROSTVRTX
| Q4 25 | $511.9M | $1.2B | ||
| Q3 25 | $508.0M | $1.1B | ||
| Q2 25 | $479.2M | $1.0B | ||
| Q1 25 | $586.8M | $646.3M | ||
| Q4 24 | $488.8M | $913.0M | ||
| Q3 24 | $527.1M | $1.0B | ||
| Q2 24 | $488.0M | $-3.6B | ||
| Q1 24 | $609.7M | $1.1B |
毛利率ROSTVRTX
| Q4 25 | 28.0% | 85.4% | ||
| Q3 25 | 27.6% | 86.5% | ||
| Q2 25 | 28.2% | 86.3% | ||
| Q1 25 | 26.5% | 86.9% | ||
| Q4 24 | 28.3% | 85.5% | ||
| Q3 24 | 28.3% | 85.8% | ||
| Q2 24 | 28.1% | 85.9% | ||
| Q1 24 | 27.3% | 87.3% |
营业利润率ROSTVRTX
| Q4 25 | 11.6% | 37.8% | ||
| Q3 25 | 11.5% | 38.6% | ||
| Q2 25 | 12.2% | 38.8% | ||
| Q1 25 | 12.4% | 22.7% | ||
| Q4 24 | 11.9% | 35.2% | ||
| Q3 24 | 12.5% | 40.3% | ||
| Q2 24 | 12.2% | -132.9% | ||
| Q1 24 | 13.2% | 42.4% |
净利率ROSTVRTX
| Q4 25 | 9.1% | 37.3% | ||
| Q3 25 | 9.2% | 35.2% | ||
| Q2 25 | 9.6% | 34.8% | ||
| Q1 25 | 9.9% | 23.3% | ||
| Q4 24 | 9.6% | 31.4% | ||
| Q3 24 | 10.0% | 37.7% | ||
| Q2 24 | 10.0% | -135.8% | ||
| Q1 24 | 10.1% | 40.9% |
每股收益（稀释后）ROSTVRTX
| Q4 25 | $1.58 | $4.64 | ||
| Q3 25 | $1.56 | $4.20 | ||
| Q2 25 | $1.47 | $3.99 | ||
| Q1 25 | $1.79 | $2.49 | ||
| Q4 24 | $1.48 | $3.62 | ||
| Q3 24 | $1.59 | $4.01 | ||
| Q2 24 | $1.46 | $-13.92 | ||
| Q1 24 | $1.82 | $4.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.1B | $6.6B |
| 总债务越低越好 | $1.5B | — |
| 股东权益账面价值 | $5.9B | $18.7B |
| 总资产 | $15.4B | $25.6B |
| 负债/权益比越低杠杆越低 | 0.26× | — |
8季度趋势，按日历期对齐
现金及短期投资ROSTVRTX
| Q4 25 | $4.1B | $6.6B | ||
| Q3 25 | $3.8B | $6.3B | ||
| Q2 25 | $3.8B | $6.4B | ||
| Q1 25 | $4.7B | $6.2B | ||
| Q4 24 | $4.3B | $6.1B | ||
| Q3 24 | $4.7B | $6.5B | ||
| Q2 24 | $4.7B | $5.8B | ||
| Q1 24 | $4.9B | $10.2B |
总债务ROSTVRTX
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.2B | — | ||
| Q3 24 | $2.5B | — | ||
| Q2 24 | $2.5B | — | ||
| Q1 24 | $2.5B | — |
股东权益ROSTVRTX
| Q4 25 | $5.9B | $18.7B | ||
| Q3 25 | $5.7B | $17.3B | ||
| Q2 25 | $5.6B | $17.2B | ||
| Q1 25 | $5.5B | $16.5B | ||
| Q4 24 | $5.3B | $16.4B | ||
| Q3 24 | $5.1B | $15.6B | ||
| Q2 24 | $4.9B | $14.8B | ||
| Q1 24 | $4.9B | $18.5B |
总资产ROSTVRTX
| Q4 25 | $15.4B | $25.6B | ||
| Q3 25 | $14.5B | $24.9B | ||
| Q2 25 | $14.3B | $24.0B | ||
| Q1 25 | $14.9B | $22.9B | ||
| Q4 24 | $14.9B | $22.5B | ||
| Q3 24 | $14.7B | $22.2B | ||
| Q2 24 | $14.5B | $20.1B | ||
| Q1 24 | $14.3B | $23.9B |
负债/权益比ROSTVRTX
| Q4 25 | 0.26× | — | ||
| Q3 25 | 0.26× | — | ||
| Q2 25 | 0.27× | — | ||
| Q1 25 | 0.40× | — | ||
| Q4 24 | 0.42× | — | ||
| Q3 24 | 0.48× | — | ||
| Q2 24 | 0.50× | — | ||
| Q1 24 | 0.51× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $827.1M | $498.0M |
| 自由现金流经营现金流 - 资本支出 | $617.8M | $348.6M |
| 自由现金流率自由现金流/营收 | 11.0% | 10.9% |
| 资本支出强度资本支出/营收 | 3.7% | 4.7% |
| 现金转化率经营现金流/净利润 | 1.62× | 0.42× |
| 过去12个月自由现金流最近4个季度 | $2.0B | $3.2B |
8季度趋势，按日历期对齐
经营现金流ROSTVRTX
| Q4 25 | $827.1M | $498.0M | ||
| Q3 25 | $668.4M | $1.2B | ||
| Q2 25 | $409.7M | $1.1B | ||
| Q1 25 | $882.6M | $818.9M | ||
| Q4 24 | $513.4M | $584.6M | ||
| Q3 24 | $592.1M | $1.4B | ||
| Q2 24 | $368.9M | $-3.8B | ||
| Q1 24 | $948.8M | $1.3B |
自由现金流ROSTVRTX
| Q4 25 | $617.8M | $348.6M | ||
| Q3 25 | $466.6M | $1.1B | ||
| Q2 25 | $202.3M | $927.4M | ||
| Q1 25 | $676.6M | $778.2M | ||
| Q4 24 | $333.0M | $492.0M | ||
| Q3 24 | $394.6M | $1.3B | ||
| Q2 24 | $232.7M | $-3.8B | ||
| Q1 24 | $726.4M | $1.2B |
自由现金流率ROSTVRTX
| Q4 25 | 11.0% | 10.9% | ||
| Q3 25 | 8.4% | 37.0% | ||
| Q2 25 | 4.1% | 31.3% | ||
| Q1 25 | 11.4% | 28.1% | ||
| Q4 24 | 6.6% | 16.9% | ||
| Q3 24 | 7.5% | 47.0% | ||
| Q2 24 | 4.8% | -144.5% | ||
| Q1 24 | 12.1% | 46.0% |
资本支出强度ROSTVRTX
| Q4 25 | 3.7% | 4.7% | ||
| Q3 25 | 3.6% | 3.3% | ||
| Q2 25 | 4.2% | 4.9% | ||
| Q1 25 | 3.5% | 1.5% | ||
| Q4 24 | 3.6% | 3.2% | ||
| Q3 24 | 3.7% | 2.4% | ||
| Q2 24 | 2.8% | 2.6% | ||
| Q1 24 | 3.7% | 2.5% |
现金转化率ROSTVRTX
| Q4 25 | 1.62× | 0.42× | ||
| Q3 25 | 1.32× | 1.15× | ||
| Q2 25 | 0.85× | 1.04× | ||
| Q1 25 | 1.50× | 1.27× | ||
| Q4 24 | 1.05× | 0.64× | ||
| Q3 24 | 1.12× | 1.31× | ||
| Q2 24 | 0.76× | — | ||
| Q1 24 | 1.56× | 1.19× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ROST
暂无分部数据
VRTX
| TRIKAFTAKAFTRIO | $2.6B | 81% |
| ALYFTREK | $380.1M | 12% |
| Manufactured Product Other | $237.4M | 7% |
